Upcoming Talks Considerations to Improve Patient Outcomes in Early Drug Development Embracing Choice Without Sacrificing Time-to-Results with Intel on Azure HPC On Demand Talks Bioengineering for renewable energy and a sustainable future Investing in Psychedelics: Opportunities and Challenges for 2022 Lesson learnt from MarkLogic's Customers & Partners experiences Enhancing cancer care and research through data protection Deep Learning Data Exploration for Healthcare and Life Sciences Alternative Designs to Traditional 3+3 Design in Phase 1 Dose Escalation Studies Pharma Contract Services - Investment Opportunities and Trends 1상 용량 증량 연구에서 전통적 3+3 디자인의 대체에 관한 통찰 Optimizing Omnichannel Marketing in Pharma Considerations to Improve Patient Outcomes in Early Drug Development Explore all talks
